Cormorant Asset Management as of Sept. 30, 2023
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 49 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 27.1 | $464M | 8.1M | 57.00 | |
| Bridgebio Pharma (BBIO) | 7.2 | $123M | 4.7M | 26.37 | |
| Ambrx Biopharma Sponsored Ads | 6.7 | $114M | 9.9M | 11.50 | |
| Arcellx Common Stock (ACLX) | 4.5 | $77M | 2.2M | 35.88 | |
| Apellis Pharmaceuticals (APLS) | 4.4 | $76M | 2.0M | 38.04 | |
| Cymabay Therapeutics | 3.3 | $57M | 3.9M | 14.91 | |
| Olema Pharmaceuticals (OLMA) | 3.2 | $56M | 4.5M | 12.35 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 3.1 | $53M | 1.1M | 50.42 | |
| Biomea Fusion (BMEA) | 2.9 | $49M | 3.6M | 13.76 | |
| Immunovant (IMVT) | 2.7 | $47M | 1.2M | 38.39 | |
| Tarsus Pharmaceuticals (TARS) | 2.7 | $47M | 2.6M | 17.77 | |
| Cabaletta Bio (CABA) | 2.6 | $44M | 2.9M | 15.22 | |
| Vaxcyte (PCVX) | 2.0 | $34M | 665k | 50.98 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.9 | $33M | 1.1M | 29.74 | |
| Immuneering Corp Class A Com (IMRX) | 1.9 | $32M | 4.2M | 7.68 | |
| Pharvaris N V (PHVS) | 1.7 | $28M | 1.4M | 20.87 | |
| Rayzebio | 1.5 | $26M | 1.2M | 22.20 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 1.5 | $26M | 3.2M | 7.99 | |
| Karuna Therapeutics Ord | 1.4 | $24M | 140k | 169.09 | |
| Alpine Immune Sciences | 1.3 | $22M | 1.9M | 11.45 | |
| Erasca (ERAS) | 1.2 | $21M | 11M | 1.97 | |
| Aerovate Therapeutics (AVTE) | 1.2 | $21M | 1.6M | 13.57 | |
| Marinus Pharmaceuticals Com New (MRNS) | 1.2 | $21M | 2.6M | 8.05 | |
| Rhythm Pharmaceuticals (RYTM) | 1.1 | $20M | 850k | 22.93 | |
| Edgewise Therapeutics (EWTX) | 1.0 | $17M | 2.9M | 5.73 | |
| Enliven Therapeutics (ELVN) | 1.0 | $17M | 1.2M | 13.66 | |
| Praxis Precision Medicines I | 0.9 | $16M | 9.5M | 1.71 | |
| Ideaya Biosciences (IDYA) | 0.9 | $16M | 600k | 26.98 | |
| Insmed Com Par $.01 (INSM) | 0.8 | $15M | 575k | 25.25 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.8 | $14M | 700k | 20.06 | |
| Axonics Modulation Technolog (AXNX) | 0.8 | $14M | 250k | 56.12 | |
| Longboard Pharmaceuticals In (LBPH) | 0.8 | $13M | 2.4M | 5.56 | |
| Avidity Biosciences Ord (RNA) | 0.7 | $11M | 1.8M | 6.38 | |
| Disc Medicine (IRON) | 0.6 | $11M | 225k | 46.98 | |
| Cogent Biosciences (COGT) | 0.6 | $9.8M | 1.0M | 9.75 | |
| Rocket Pharmaceuticals (RCKT) | 0.5 | $9.2M | 450k | 20.49 | |
| Gh Research Ordinary Shares (GHRS) | 0.3 | $6.0M | 593k | 10.05 | |
| Rapt Therapeutics (RAPT) | 0.3 | $5.4M | 325k | 16.62 | |
| Verve Therapeutics (VERV) | 0.3 | $4.6M | 350k | 13.26 | |
| Stoke Therapeutics (STOK) | 0.3 | $4.3M | 1.1M | 3.94 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.2 | $3.6M | 562k | 6.47 | |
| Vigil Neuroscience (VIGL) | 0.2 | $3.3M | 617k | 5.39 | |
| Alx Oncology Hldgs (ALXO) | 0.2 | $2.9M | 612k | 4.80 | |
| Biohaven (BHVN) | 0.1 | $2.1M | 82k | 26.01 | |
| Bioatla (BCAB) | 0.1 | $2.0M | 1.2M | 1.70 | |
| Neumora Therapeutics (NMRA) | 0.1 | $1.3M | 92k | 14.11 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $914k | 392k | 2.33 | |
| Harpoon Therapeutics Com New | 0.0 | $218k | 54k | 4.03 | |
| Orchard Therapeutics Spon Ads New | 0.0 | $198k | 26k | 7.73 |
